FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
+9.04%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$126M
AUM Growth
-$6.16M
(-4.7%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-10.09%
Top 10 Holdings %
Top 10 Hldgs %
76.69%
Holding
63
New
10
Increased
21
Reduced
12
Closed
6
Top Buys
| 1 |
JD.com
JD
|
+$4.13M |
| 2 |
TAL Education Group
TAL
|
+$3.65M |
| 3 |
Ultrapar
UGP
|
+$2.12M |
| 4 |
Petrobras Class A
PBR.A
|
+$1.12M |
| 5 |
Baidu
BIDU
|
+$1.05M |
Top Sells
| 1 |
CTCM
CTC MEDIA INC COM STK
CTCM
|
+$7.89M |
| 2 |
Compañía de Cervecerías Unidas
CCU
|
+$7.37M |
| 3 |
Vale
VALE
|
+$6.34M |
| 4 |
Fomento Económico Mexicano
FMX
|
+$3.47M |
| 5 |
Itaú Unibanco
ITUB
|
+$1.47M |
Sector Composition
| 1 | Financials | 24.67% |
| 2 | Consumer Staples | 24.25% |
| 3 | Communication Services | 22.05% |
| 4 | Energy | 10.54% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OREX
26
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $217K | 0.17% |
3,520
+690
| +24% | +$42.5K |
|
27
Bristol-Myers Squibb
BMY
$94.9B
| $214K | 0.17% |
4,427
+605
| +16% | +$29.2K |
|
28
Viatris
VTRS
$11.3B
| $209K | 0.17% |
4,080
+595
| +17% | +$30.5K |
|
29
Insulet
PODD
$22.7B
| $193K | 0.15% |
4,868
| – | – |
|
30
Thermo Fisher Scientific
TMO
$180B
| $191K | 0.15% |
1,622
+336
| +26% | +$39.6K |
|
|
MDVN
31
DELISTED
MEDIVATION, INC.
MDVN
| $176K | 0.14% |
4,588
| – | – |
|
32
Medtronic
MDT
$121B
| $173K | 0.14% |
2,718
| – | – |
|
|
FRX
33
DELISTED
FOREST LABORATORIES INC
FRX
| $167K | 0.13% |
1,685
+416
| +33% | +$41.2K |
|
34
Sanofi
SNY
$115B
| $143K | 0.11% |
2,700
| – | – |
|
35
Innoviva
INVA
$1.23B
| $135K | 0.11% |
4,532
-869
| -16% | -$25.9K |
|
36
Theravance Biopharma
TBPH
$702M
| $135K | 0.11% |
+4,340
| New | +$135K |
|
37
Amgen
AMGN
$148B
| $126K | 0.1% |
1,065
| – | – |
|
38
Becton Dickinson
BDX
$54.1B
| $124K | 0.1% |
1,076
+362
| +51% | +$41.7K |
|
39
Illumina
ILMN
$15.5B
| $121K | 0.1% |
701
-278
| -28% | -$48K |
|
40
Abbott
ABT
$232B
| $117K | 0.09% |
2,855
+915
| +47% | +$37.5K |
|
|
IPXL
41
DELISTED
Impax Laboratories, Inc.
IPXL
| $86K | 0.07% |
+2,865
| New | +$86K |
|
|
PCYC
42
DELISTED
PHARMACYCLICS INC
PCYC
| $84K | 0.07% |
937
+418
| +81% | +$37.5K |
|
|
SLXP
43
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $84K | 0.07% |
681
-387
| -36% | -$47.7K |
|
44
Boston Scientific
BSX
$146B
| $77K | 0.06% |
+6,060
| New | +$77K |
|
45
Biogen
BIIB
$21.2B
| $74K | 0.06% |
236
| – | – |
|
|
NPSP
46
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $62K | 0.05% |
1,876
| – | – |
|
|
NSTG
47
DELISTED
NanoString Technologies, Inc.
NSTG
| $61K | 0.05% |
4,081
| – | – |
|
|
CELG
48
DELISTED
Celgene Corp
CELG
| $60K | 0.05% |
696
| – | – |
|
49
IQVIA
IQV
$32.1B
| $52K | 0.04% |
973
| – | – |
|
50
Incyte
INCY
$16.7B
| $43K | 0.03% |
+769
| New | +$43K |
|